Attached files
| file | filename |
|---|---|
| 10-K - NURX PHARMACEUTICALS, INC. | v169993_10k.htm |
| EX-31.2 - NURX PHARMACEUTICALS, INC. | v169993_ex31-2.htm |
| EX-32.1 - NURX PHARMACEUTICALS, INC. | v169993_ex32-1.htm |
| EX-31.1 - NURX PHARMACEUTICALS, INC. | v169993_ex31-1.htm |
Exhibit
32.2
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the annual report of NuRx Pharmaceuticals, Inc. (the “Company”)
on Form 10-K for the year ending September 30, 2009, as filed with the
Securities and Exchange Commission (the “Report”), I, Steven Gershick, Chief
Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:
1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and
2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
Date:
December 29, 2009
|
/s/ Steven Gershick
|
|
|
Name:
|
Steven
Gershick
|
|
Title:
|
Chief
Financial Officer
|
|
(principal
financial officer)
|
|